How do follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, and sex-hormone-binding globulin (SHBG) affect testosterone production in men?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How FSH, LH, Prolactin, and SHBG Affect Testosterone Production in Men

Luteinizing hormone (LH) directly stimulates testosterone production by Leydig cells in the testes, while FSH indirectly supports testosterone production through Sertoli cell function; prolactin elevation suppresses the hypothalamic-pituitary-gonadal (HPG) axis reducing both LH and testosterone; and SHBG does not affect testosterone production itself but regulates the bioavailability of free testosterone by binding it in circulation.

The Hypothalamic-Pituitary-Gonadal Axis Framework

The HPG axis operates through negative feedback: the hypothalamus releases GnRH, which stimulates the pituitary to secrete LH and FSH, which then act on the testes. Testosterone and other testicular factors feed back to suppress GnRH, LH, and FSH secretion 1.

Luteinizing Hormone (LH): The Direct Driver

LH is the primary and direct stimulator of testosterone production. LH binds to receptors on Leydig cells in the testicular interstitium, triggering testosterone synthesis through the steroidogenic pathway 2.

  • Clinical evidence demonstrates LH's critical role: A man with a mutant LH beta subunit producing only 1-2% of normal testosterone still maintained complete spermatogenesis, proving that even minimal LH stimulation can sustain testosterone production when Leydig cells are present 2
  • Inverse relationship with testosterone: Blood LH concentrations show a significant reciprocal correlation with testosterone levels—when testosterone is low, LH rises in an attempt to stimulate more production 3
  • Secondary hypogonadism: Low LH with low testosterone indicates hypothalamic or pituitary dysfunction, while high LH with low testosterone indicates primary testicular failure 1

Follicle-Stimulating Hormone (FSH): The Indirect Supporter

FSH does not directly stimulate testosterone production but enhances it indirectly through Sertoli cell-mediated mechanisms. FSH acts exclusively on Sertoli cells, which lack the enzymatic machinery for testosterone synthesis 4, 2.

  • Sertoli cell intermediary: FSH stimulates Sertoli cells to release non-steroid factors (molecular mass >50 kDa) that amplify Leydig cell responsiveness to LH, increasing testosterone production 5
  • Demonstrated effect: Administration of recombinant FSH (150 IU IV) increased spermatic vein testosterone by 124% (from 326 to 732 ng/mL) within 30 minutes, with increased testosterone/androstenedione and testosterone/DHEA ratios, indicating enhanced 17β-hydroxysteroid dehydrogenase activity 5
  • Synergistic action: FSH and testosterone together support qualitatively and quantitatively normal spermatogenesis, though FSH's primary role is in Sertoli cell number determination and germ cell proliferation 4

Prolactin: The Suppressor

Elevated prolactin (hyperprolactinemia) suppresses testosterone production by inhibiting GnRH secretion, which reduces LH and FSH release. This represents a functional cause of secondary hypogonadism 6.

  • Clinical threshold: Persistent hyperprolactinemia warrants pituitary imaging, especially when combined with severe secondary hypogonadism (testosterone <150 ng/dL), to exclude prolactinoma or other pituitary pathology 6
  • Mechanism: Prolactin acts at the hypothalamic level to suppress GnRH pulsatility, thereby reducing gonadotropin secretion and subsequent testosterone production
  • Reversibility: Unlike structural pituitary disease, hyperprolactinemia-induced hypogonadism is potentially reversible with treatment of the underlying cause 1

Sex Hormone-Binding Globulin (SHBG): The Bioavailability Regulator

SHBG does not affect testosterone production but critically determines how much testosterone is biologically available (free testosterone). Only 2-4% of circulating testosterone is unbound or "free," with most bound to SHBG (high affinity) and albumin (low affinity) 6.

SHBG's Clinical Significance

  • The free hormone hypothesis: Intracellular testosterone concentrations and biological activity depend on free rather than protein-bound testosterone 6
  • Critical validation: European Male Aging Study data showed that men with low free testosterone had sexual and physical symptoms of testosterone deficiency regardless of total testosterone levels, while men with low total testosterone but normal free testosterone (typically obese with low SHBG) had no deficiency symptoms 6

Factors Affecting SHBG Levels 1:

SHBG increases with:

  • Aging
  • Hyperthyroidism
  • Hepatic disease
  • Drugs: anticonvulsants, estrogens, thyroid hormone
  • Smoking
  • HIV/AIDS

SHBG decreases with:

  • Obesity (most common)
  • Insulin resistance, metabolic syndrome, type 2 diabetes
  • Hypothyroidism
  • Drugs: growth hormone, glucocorticoids, testosterone, anabolic steroids
  • Cushing's disease, acromegaly
  • Nonalcoholic fatty liver disease, nephrotic syndrome

When to Measure Free Testosterone

Measure free testosterone in men with conditions that alter SHBG levels or when total testosterone is 200-400 ng/dL 6.

  • Low SHBG conditions (obesity, diabetes): Total testosterone may be falsely low while free testosterone remains normal
  • High SHBG conditions (aging, HIV, anticonvulsants): Total testosterone may be normal or high while free testosterone is actually low
  • Below 150 ng/dL total testosterone: Free testosterone measurement is unnecessary as it will almost certainly be low 6

Integrated Hormonal Regulation

The system operates through coordinated feedback:

  1. LH directly stimulates Leydig cells → testosterone production
  2. FSH stimulates Sertoli cells → release factors that amplify LH's effect on Leydig cells → enhanced testosterone production
  3. Testosterone feeds back to suppress GnRH, LH, and FSH secretion
  4. Prolactin elevation suppresses GnRH → reduces LH and FSH → decreases testosterone production
  5. SHBG binds testosterone in circulation → determines free testosterone availability → influences feedback signaling

Clinical Implications

When evaluating testosterone status 1, 6:

  • Measure morning total testosterone on two separate occasions
  • Check LH and FSH to distinguish primary (high LH/FSH) from secondary (low/normal LH/FSH) hypogonadism
  • Measure prolactin to exclude hyperprolactinemia as a reversible cause
  • Measure free testosterone or calculate it when SHBG-altering conditions exist (obesity, diabetes, aging, medications)
  • Consider that functional hypogonadism from obesity and metabolic disorders can be reversed with weight loss, which normalizes both testosterone levels and gonadotropin secretion 1

Related Questions

In a male patient with elevated follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) but normal serum testosterone, what is the most likely cause and recommended diagnostic work‑up?
What are the treatment options for a man with elevated Follicle-Stimulating Hormone (FSH) levels?
What is the differential diagnosis for persistently elevated total testosterone in a male with normal follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) levels?
What are the differential diagnoses for elevated follicle‑stimulating hormone (FSH) and luteinising hormone (LH) with normal testosterone levels?
What are the possible causes of low testosterone in a man with normal follicle‑stimulating hormone (FSH), luteinizing hormone (LH), prolactin, cortisol, and thyroid‑stimulating hormone (TSH)?
How should glucagon be administered to relax esophageal smooth muscle and aid passage of a lodged foreign body?
What is the recommended starting dose of the beta‑blocker bisoprolol for adults with hypertension or angina, and for patients with chronic heart failure?
What is the recommended dosing regimen for oral ketoconazole for systemic fungal infections, including loading and maintenance doses and required monitoring?
Will piperacillin‑tazobactam (Zosyn) provide adequate antimicrobial coverage for a chronic obstructive pulmonary disease (COPD) exacerbation?
What is the recommended pyrazinamide dosage for an adult with active tuberculosis?
Should calcium gluconate be given after the fourth unit of stored blood transfusion to prevent citrate‑induced hypocalcemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.